This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Millar, Inc. is pleased to announce an official collaboration agreement with AMFitzgerald to serve OEM customers seeking a complete sensor solution using micro-electromechanical systems (MEMS) technology. This agreement arises from a long history of MEMS technology development between the two companies and furthers each company's vision to better serve the growing interest in the medical device and clinical communities for increased in vivo physiologic data.
The clinical market has experienced an upward trend of sensor integration into existing medical technologies, especially in the cardiovascular market, to enable improved patient monitoring, diagnostics and outcomes. Due to their small size, low power consumption, and low cost, MEMS sensors offer exciting new capabilities to gather in situ data at locations in the body which cannot be otherwise accessed. Pressure, temperature, motion, and flow parameters may now be directly measured.
AMFitzgerald develops innovative MEMS and sensor solutions for specialty applications. Its primary business is in design and development of custom MEMS sensors and actuators and selection of commercially-available sensors for implementation in medical and other high performing applications.
By leveraging Millar's ISO-13485 quality control certification and 45+ years of MEMS-enabled product manufacturing expertise, AMFitzgerald can provide advanced and proven solutions for sensor testing, wire attach, and biocompatible encapsulation, delivering OEM customers a fully-packaged sensor module solution for medical device integration. The end result will be a faster path to market for companies that work with the AMFitzgerald and Millar teams.
